Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment ...
The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals and ...
The federal Centers for Medicare and Medicaid Services (CMS) issued QSO-25-09-ALL on November 21, 2024, revising Core Appendix Q guidance to the ...
At least two parents at Rama Road Elementary School complained that the school had no heat for two days this week. One parent ...
Bluebird bio (BLUE) and Vertex (VRTX) have entered into outcome-based agreements with CMS aimed at expanding patient access ...
After both insurers challenged the agency in court, the CMS improved scores for 12 UnitedHealth contracts and seven Centene ...
“Cell and gene therapies hold significant potential to improve patient outcomes and transform lives, ultimately reducing long ...
The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule aimed at bolstering protections, enhancing ...
On Nov. 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that will increase payments to end-stage renal disease ...
UnitedHealthcare successfully won its lawsuit over the Centers for Medicare and Medicaid Services, a federal judge determined ...
Effective enforcement of the Hospital Price Transparency Rule can empower patients, foster competition, and help control ...
The revised guidance eliminates "culpability" as a required element for immediate jeopardy citations. Instead, surveyors must focus on whether noncompliance caused, or is likely to cause, serious harm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback